EPACUBE, INC. – Trademark Portfolio
Entity Type: 03
EPACUBE, INC. holds 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 10 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include EPACUBE, SYNCHRONIZER, and EPACUBE PROFIT OPTIMIZER. The owner is based in DALLAS, TX.
18352 DALLAS PKWY 136-392
DALLAS, TX 75287
Showing of trademarks Trademarks
Trademark Classifications
EPACUBE, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does EPACUBE, INC. have?
EPACUBE, INC. has 13 U.S. trademarks filed with the USPTO. Of these, 3 registered, 9 abandoned, 1 cancelled.
What trademark classes does EPACUBE, INC. file in?
EPACUBE, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are EPACUBE, INC.'s most well-known trademarks?
EPACUBE, INC.'s registered trademark portfolio includes well-known marks such as EPACUBE, SYNCHRONIZER, and EPACUBE PROFIT OPTIMIZER. These are among 3 currently registered trademarks in the portfolio.
What is EPACUBE, INC.'s trademark registration success rate?
EPACUBE, INC. has a 23% trademark registration rate, with 3 out of 13 resolved applications resulting in successful registration. Currently, 0 applications are pending review.